← Eichor
Condition: Intravitreal Injections Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Intravitreal Injections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
Phase 2 · 1 location(s) · Innovent Biologics Technology Limited (Shanghai R&D Center) · NCT07275840Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment
Phase 4 · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT07133438A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participant
Phase 3 · 36 location(s) · Amgen · NCT07614776Eye Diseases "Treated" With Interoperable Medical Informatics
Phase N/A · 6 location(s) · University Hospital Muenster · NCT06810011Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Phase 1 · 2 location(s) · Benobio Co., Ltd. · NCT05803785Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema
Phase 2 · 1 location(s) · Alexandria University · NCT06845163Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Phase 2/Phase 3 · 1 location(s) · Isfahan University of Medical Sciences · NCT06595355Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Pla
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05706896Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients
Phase 1/Phase 2 · 3 location(s) · Ray Therapeutics, Inc. · NCT07439887Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
NA · 1 location(s) · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06893965Effect of Video Viewing on Intravitreal Injection Experience
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07002372Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT06749639Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma.
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06536062Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Phase 2 · 14 location(s) · jCyte, Inc · NCT06912633Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Preventio
Phase 3 · 25 location(s) · Jaeb Center for Health Research · NCT05844982Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Dia
NA · 1 location(s) · Tianjin Medical University Eye Hospital · NCT05728476An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
Phase 1 · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06936787A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Se
Phase 1/Phase 2 · 18 location(s) · Sanofi · NCT07215234Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · 94 location(s) · 4D Molecular Therapeutics · NCT07064759A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degenera
Phase 1 · 3 location(s) · Youxin Chen · NCT06213038Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT06894017Incidence of Hypoxia During Intravitreal Anti-VEGF (Vascular Endothelial Growth Factor) Injections for Retinopathy of Pr
Phase N/A · 1 location(s) · Minia University · NCT07701759Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients
Phase 2 · 1 location(s) · GenSight Biologics · NCT07303296A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With D
Phase 1 · 10 location(s) · Genentech, Inc. · NCT07425522Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
Phase 1/Phase 2 · 1 location(s) · Mahidol University · NCT06242379Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT07656753Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients
NA · 2 location(s) · University Hospital, Alexandroupolis · NCT06929507Aflibercept in Recurrent or Persistent CNV
Phase N/A · 1 location(s) · Medical University of Vienna · NCT02669953Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Phase 1/Phase 2 · 9 location(s) · Skyline Therapeutics (US) Inc. · NCT05986864Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT
NA · 1 location(s) · Prince of Songkla University · NCT03648814
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.